Systematic review of Swedish snus for smoking cessation based on primary subject data from randomised clinical trials

Journal of Smoking Cessation

Volumn 8, Issue 1, 2013, Pages 33-44

  Rutqvist, L E ^a   Fry, J S ^b   Lee, P N ^b  

^a Swedish Match AB   (Sweden)

^b P N Lee Statistics and Computing Ltd   (United Kingdom)

Author keywords

randomised trial; smoking cessation; Swedish snus; Systematic review

Indexed keywords

EID: 84880569139     PISSN: None     EISSN: 18342612     Source Type: Journal    
DOI: 10.1017/jsc.2013.10     Document Type: Review

References (26)

1. Royal College of Physicians (ed.). (2002). Protecting smokers, saving lives: the case for a tobacco and nicotine regulatory authority. London: Royal College of Physicians. http://www.rcplondon.ac.uk/pubs/books/protsmokers/ ProtSmokers.pdf
2. Breslow, N. E., & Day, N. E. (1980). The analysis of case-control studies. Vol. 1. Statistical methods in cancer research, W. Davis (Ed.). (IARC Scientific Publication No. 32.) Lyon: IARC.
3. Conover, W. J. (2003). Practical nonparametric statistics. 3rd edition. Wiley series in probability and mathematical statistics, R. A. Bradley, J. S. Hunter, D. G. Kendall, & G. S. Watson (Eds.). New York, Chichester, Brisbane, Toronto: John Wiley & Sons.
4. Fagerström, K., Rutqvist, L., & Hughes, J. (2011). Snus as a smoking cessation aid: a randomized, placebo-controlled trial. Nicotine & Tobacco Research, 14, 306-312.
5. Fleiss, J. L., & Gross, A. J. (1991). Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. Journal of Clinical Epidemiology, 44, 127-139.
6. Foulds, J., Ramström, L., Burke, M., & Fagerström, K. (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12, 349-359. (Pubitemid 39452035)
7. Fry, J. S., & Lee, P. N. (1991). A stratified Wilcoxon-type test for trend (Letter). Statistics In Medicine, 10, 799-800.
8. Greenland, S., & Robins, J. M. (1985). Estimation of a common effect parameter from sparse follow-up data. Biometrics, 41, 55-68.
9. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., & Fagerström, K.O. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. British Journal of Addiction, 86, 1119-1127.
10. Holm, L.-E., Fisker, J., Larsen, B.-I., Puska, P., & Halldórsson, M. (2009). Snus does not save lives: quitting smoking does! Tobacco Control, 18, 250-251.
11. Hughes, J. R., Benowitz, N., Hatsukami, D., Mermelstein, R. J., & Shiffman, S. (2004). Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies. Nicotine & Tobacco Research, 5, 863-864. (Pubitemid 39504461)
12. Hughes, J. R., & Carpenter, M. J. (2006). Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine & Tobacco Research, 8, 739-749. (Pubitemid 44842952)
13. Joksic, G., Spasojevic-Tisma, V., Antic, R., Nilsson, R., & Rutqvist, L. E. (2011). Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation. Harm Reduction Journal, 8, 25.
14. Katz, D., Baptista, J., Azen, S. P., & Pike, M. C. (1978). Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics, 34, 469-474. (Pubitemid 9016019)
15. Lee, P. N. (2011). Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology: RTP, 59, 197-214.
16. Lee, P. N., & Hamling, J. S. (2009). Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Medicine, 7, 36.
17. Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339, b2700.
18. Lund, K. E., McNeill, A., & Scheffels, J. (2010). The use of snus for quitting smoking compared with medicinal products. Nicotine & Tobacco Research, 12, 817-822.
19. Pisinger, C, & Godtfredsen, N. S. (2007). Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine & Tobacco Research, 9, 631-646. (Pubitemid 46930313)
20. Ramström, L. M., & Foulds, J. (2006). Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control, 15, 210-214. (Pubitemid 43864877)
21. Rodu, B., & Cole, P. (2004). The burden of mortality from smoking: comparing Sweden with other countries in the European Union. European Journal of Epidemiology, 19, 129-131. (Pubitemid 38374562)
22. Rutqvist, L. E., Curvall, M., Hassler, T., Ringberger, T., & Wahlberg, I. (2011). Swedish snus and the GothiaTek® standard. Harm Reduction Journal, 8, 11.
23. Sæterdal, I., Harboe, I., Ringerike, T., & Klemp, M. (2012). Snus som røykeavvenningsmiddel - systematisk litteratursøk med sortering. Notat 2012. Oslo: Nasjonalt kunnskapssenter for helsetjenesten. http://www.kunnskapssenteret.no/Publikasjoner
24. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). (2008, (Accessed Oct 2010)). Health effects of smokeless tobacco products. Brussels: European Commission, Health & Consumer Protection Directorate-General. http://ec.europa.eu/health/ph-risk/committees/04-scenihr/ docs/scenihr-o-013.pdf
25. Wikström, A.-K., Cnattingius, S., Galanti, M. R., Kieler, H., & Stephansson, O. (2010a). Effect of Swedish snuff (snus) on preterm birth. BJOG: an International Journal of Obstetrics and Gynaecology, 117, 1005-1010.
26. Wikström, A. K., Cnattingius, S., & Stephansson, O. (2010b). Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiology, 21, 772-778.